Citadel Advisors’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,062,354
Closed -$10.6M 15921
2022
Q4
$10.6M Hold
1,062,354
﹤0.01% 2745
2022
Q3
$10.4M Hold
1,062,354
﹤0.01% 2695
2022
Q2
$10.3M Buy
1,062,354
+224
+0% +$2.17K ﹤0.01% 2650
2022
Q1
$10.3M Sell
1,062,130
-582
-0.1% -$5.63K ﹤0.01% 2896
2021
Q4
$10.3M Sell
1,062,712
-131,194
-11% -$1.29M ﹤0.01% 3033
2021
Q3
$11.8M Buy
+1,193,906
New +$11.9M ﹤0.01% 2780

Other funds holding ARYE

Citadel Advisors's ARYE Position: Q1 2023 in Review

Citadel Advisors sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q1 2023, closing a stake of 1,062,354 shares — an estimated $10.6M sold.

Citadel Advisors first reported a position in ARYE in Q3 2021 and held it in 6 quarters. The position peaked at $11.8M in Q3 2021. 48 funds tracked by Wall St. Rank hold ARYE as of Q1 2023.

  • Citadel Advisors reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,062,354 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q1 2023, an estimated $10.6M.
  • Citadel Advisors first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
  • Citadel Advisors's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $11.8M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.